These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24453047)

  • 1. Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis.
    Ng CF; Xu JY; Li MS; Tsui SK
    J Cell Biochem; 2014 Apr; 115(4):744-53. PubMed ID: 24453047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FHL2 regulation in the transcriptional circuitry of human cancers.
    Cao CY; Mok SW; Cheng VW; Tsui SK
    Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
    J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
    Chen YH; Wu ZQ; Zhao YL; Si YL; Guo MZ; Han WD
    Chin Med J (Engl); 2012 Jul; 125(13):2329-33. PubMed ID: 22882857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells.
    Xu J; Zhou J; Li MS; Ng CF; Ng YK; Lai PB; Tsui SK
    PLoS One; 2014; 9(8):e99359. PubMed ID: 25121502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of FHL2 attenuates airway inflammation in mice and genetic variation associates with human bronchial hyper-responsiveness.
    Kurakula K; Vos M; Logiantara A; Roelofs JJ; Nieuwenhuis MA; Koppelman GH; Postma DS; Brandsma CA; Sin DD; Bossé Y; Nickle DC; van Rijt LS; de Vries CJ
    Allergy; 2015 Dec; 70(12):1531-44. PubMed ID: 26222912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q; Wang X; Tian X; Tang R; Xu X
    J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
    Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
    Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.
    Huss S; Stellmacher C; Goltz D; Khlistunova I; Adam AC; Trebicka J; Kirfel J; Büttner R; Weiskirchen R
    BMC Gastroenterol; 2013 Jan; 13():8. PubMed ID: 23311569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL2-driven molecular network mediated Septin2 knockdown inducing apoptosis in mesangial cell.
    Lu Y; Cai G; Cui S; Geng W; Chen D; Wen J; Zhang Y; Zhang F; Xie Y; Fu B; Chen X
    Proteomics; 2014 Nov; 14(21-22):2485-97. PubMed ID: 25103794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of FHL2 in cancer.
    Zhang J; Zeng Q; She M
    Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell.
    Liu Z; Han S; Wang Y; Cui C; Zhu Q; Jiang X; Yang C; Du H; Yu C; Li Q; He H; Shen X; Chen Y; Zhang Y; Ye L; Zhang Z; Li D; Zhao X; Yin H
    Int J Biol Sci; 2019; 15(4):838-846. PubMed ID: 30906214
    [No Abstract]   [Full Text] [Related]  

  • 16. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-Only Protein Four and a Half LIM Domain Protein 2 Attenuates Development of Psoriatic Arthritis by Blocking Adam17-Mediated Tumor Necrosis Factor Release.
    Leite Dantas R; Brachvogel B; Schied T; Bergmeier V; Skryabin B; Vogl T; Ludwig S; Wixler V
    Am J Pathol; 2017 Nov; 187(11):2388-2398. PubMed ID: 28823868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.